ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,030Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 761

$549K Total Retail Price of All Prescriptions

Rank: 99 out of 761

496 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,188 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 308 279 1 3
HYDROCODONE-ACETAMINOPHEN 300 258 S3 2 5
LISINOPRIL 232 223 3 1
SIMVASTATIN 228 193 4 2
FUROSEMIDE 196 170 5 7
ZOLPIDEM TARTRATE 189 183 6 22
AMLODIPINE BESYLATE 185 183 7 6
POTASSIUM CHLORIDE 177 150 8 18
ATORVASTATIN CALCIUM 176 169 9 12
OMEPRAZOLE 146 132 10 4
GABAPENTIN 144 123 11 15
WARFARIN SODIUM 141 137 12 9
FLUTICASONE PROPIONATE 136 109 13 29
CRESTOR 127 114 14 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 110 15 35
PRAVASTATIN SODIUM 116 108 16 20
ATENOLOL 112 110 17 8
METOPROLOL SUCCINATE 109 100 18 16
SERTRALINE HCL 101 88 19 25
TAMSULOSIN HCL 101 101 19 27
METFORMIN HCL 100 79 21 10
PREDNISONE 95 87 22 30
ALLOPURINOL 92 69 23 28
TRIAMTERENE-HCTZ 92 85 23 42
ALENDRONATE SODIUM 85 85 25 21
HYDROCHLOROTHIAZIDE 76 73 26 11
CITALOPRAM HBR 72 61 27 19
NEXIUM 70 70 28 98
ZETIA 67 55 29 87
LOVASTATIN 66 66 30 17
TRAZODONE HCL 66 54 30 23
OXYCODONE-ACETAMINOPHEN 64 63 S2 32 49
CARVEDILOL 63 63 33 26
GLIMEPIRIDE 60 43 34 48
METFORMIN HCL ER 58 51 35 67
DONEPEZIL HCL 55 30 36 33
SPIRONOLACTONE 50 43 37 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.